Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Brivaracetam PK and Safety in Pediatric Epilepsy
NCT03405714Phase 2Completed
- Sponsor
- UCB
- Start
- Jun 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, open-label, single-arm trial of brivaracetam in epilepsy, sponsored by UCB. Primary endpoints: Plasma Concentration of Brivaracetam (BRV) at Day 2 and Number of Participants With Adverse Events (AEs). Started Jun 2018; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03405714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405714.